The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study

被引：19

作者：

Mikhailidis, DP

Wierzbicki, AS

机构：

[1] UCL Royal Free & Univ Coll, Sch Med, Dept Clin Biochem, London, ON NW3 2QG, Canada

[2] St Thomas Hosp, Guys Kings & St Thomas Med Sch, London SE1 7EH, England

来源：

CURRENT MEDICAL RESEARCH AND OPINION | 2002年 / 18卷 / 04期

关键词：

atorvastatin; low-density lipoprotein cholesterol; high-density lipoprotein cholesterol; GREACE study; myocardial infarction; stroke;

D O I：

10.1185/030079902125000778

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：215 / 219

页数：5

共 42 条

[1] Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention - The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study [J].

Athyros, VG ;

Papageorgiou, AA ;

Mercouris, BR ;

Athyrou, VV ;

Symeonidis, AN ;

Basayannis, EO ;

Demitriadis, DS ;

Kontopoulos, AG .

CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (04) :220-228

[2] Raising low levels of high-density lipoprotein cholesterol is an important target of therapy [J].

Boden, WE ;

Pearson, TA .

AMERICAN JOURNAL OF CARDIOLOGY, 2000, 85 (05) :645-650

[3] Statins and blood pressure regulation [J].

Borghi C. ;

Veronesi M. ;

Prandin M.G. ;

Dormi A. ;

Ambrosioni E. .

Current Hypertension Reports, 2001, 3 (4) :281-288

[4] Secondary prevention in 24,431 patients with coronary heart disease: survey in primary care [J].

Brady, AJB ;

Oliver, MA ;

Pittard, JB .

BMJ-BRITISH MEDICAL JOURNAL, 2001, 322 (7300) :1463-1463

[5]

CHENG KS, 2002, IN PRESS CARDIOVASC

[6] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

[7] Development of tachyphylaxis among patients taking HMG CoA reductase inhibitors [J].

Cromwell, WC ;

Ziajka, PE .

AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (10) :1123-1127

[8] HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data [J].

Crouse, JR ;

Byington, RP ;

Furberg, CD .

ATHEROSCLEROSIS, 1998, 138 (01) :11-24

[9] The effect of short-term lipid lowering with atorvastatin on carotid artery intima media thickness in patients with peripherial vascular disease: A pilot study [J].

Davis, M ;

Atwal, AS ;

Nair, DR ;

Jagroop, IA ;

Seifalian, AM ;

Mikhailidis, DP ;

Hamilton, G .

CURRENT MEDICAL RESEARCH AND OPINION, 2000, 16 (03) :198-204

[10]

Garmendia F, 2000, CURR MED RES OPIN, V16, P208

← 1 2 3 4 5 →